JESSICA SINGLETON: Open Payments
NPI 1750857587 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 13 payments from 7 companies in 2025. Trend: 2023 $654 · 2024 $1,131 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $69 |
| Dexcom, Inc. | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Amphastar Pharmaceuticals, Inc. | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $18 |
| Insulet Corporation | 1 | $17 |
Products named: Dexcom G6 Transmitter, Rybelsus, Ozempic, JARDIANCE, Kerendia, TWIIST, Omnipod.
Industry payments across TN — which companies pay providers there.
